moricizine has been researched along with flecainide in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (32.65) | 18.7374 |
1990's | 29 (59.18) | 18.2507 |
2000's | 3 (6.12) | 29.6817 |
2010's | 1 (2.04) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Tonkin, AM | 1 |
Lastra, AA; Nesterenko, VV; Rosenshtraukh, LV; Starmer, CF | 1 |
Greene, HL; Henthorn, RW; Katz, RJ; Roden, DM; Salerno, DM; Woosley, RL | 1 |
Akiyama, T; Barker, AH; Campbell, WB; Friedman, L; Josephson, RA; Keller, M; Papa, L; Pawitan, Y; Rubbert, P | 1 |
Sugimoto, T; Yamashita, T | 1 |
Pratt, CM | 1 |
Akhtar, M; Breithardt, G; Camm, AJ; Coumel, P; Janse, MJ; Lazzara, R; Myerburg, RJ; Schwartz, PJ; Waldo, AL; Wellens, HJ | 1 |
Lee, JH; Rosen, MR | 1 |
Akiyama, T; Greenberg, H; Kuo, CS; Pawitan, Y; Reynolds-Haertle, RA | 1 |
Somberg, J | 2 |
Kerin, NZ | 1 |
Somberg, JC | 2 |
Bigger, JT; Epstein, AE; Hallstrom, AP; Reynolds-Haertle, RA; Romhilt, DW; Wyse, DG | 1 |
Cohen, JD; Hallstrom, A; Mahmarian, J; McBride, R; Steinberg, JS; Wyse, DG | 1 |
Greene, HL; Hallstrom, AP; Huther, ML | 1 |
Bigger, JT | 2 |
Anderson, JL | 1 |
Barker, AH; Capone, RJ; Echt, DS; Greene, HL; Hallstrom, AP; McBride, R; Richardson, DW; Roden, DM | 1 |
Anderson, JL; Barker, AH; Fowles, RE; Griffith, LS; Hallstrom, AP; Ledingham, RB; Reiffel, JA; Young, JB; Yusuf, S | 1 |
Camm, AJ; Garratt, C; Ward, DE | 1 |
Scamps, F; Undrovinas, A; Vassort, G | 1 |
Roden, DM; Siddoway, LA; Woosley, RL | 1 |
Engel, T; Kelliher, GJ; Kowey, P; Wetstein, L | 1 |
Huang, SK; Marcus, FI | 1 |
Podrid, PJ | 1 |
Sanna, GP | 1 |
Duff, HJ; Oates, JA; Roden, DM; Woosley, RL | 1 |
Luck, JC; Mann, DE; Pratt, CM; Wyndham, CR | 1 |
Bigger, JT; Fleiss, JL; Rolnitzky, LM; Steinman, RC | 1 |
Anderson, JL; Carlson, M; Davies, R; Duff, HJ; Greene, HL; Hallstrom, AP; Huther, M; Kammerling, JM; Romhilt, DW | 1 |
DeMaria, A; Gottlieb, S; Greene, HL; Hallstrom, A; Huther, M; Pratt, CM; Young, JB | 1 |
Bigger, JT; Brooks, MM; Epstein, AE; Goldstein, S; Kennedy, HL; Ledingham, R; Pawitan, Y | 1 |
Anderson, JL; Buckingham, TA; Carlson, MD; Carson, PE; Hallstrom, A; Henthorn, RW; Platia, EV | 1 |
Anderson, JL; Capone, RJ; Cohen, JD; Epstein, AE; Hallstrom, AP; Liebson, PR; Rogers, WJ; Seals, AA; Wyse, DG | 1 |
Barker, AH; Brooks, MM; Capone, R; Echt, DS; Greene, HL; Liebson, PR; Mitchell, LB; Peters, RW | 1 |
Brooks, MM; Gorkin, L; Kellen, J; Morris, M; Pawitan, Y; Schoenberger, JA; Schron, EB; Shumaker, S; Verter, J; Wiklund, I | 1 |
Brezsnyak, ML; Campion, J; Corum, J; Ettinger, A; Kellen, JC; McBride, R; Schron, E; Thomas, S; Todd, L | 1 |
Dougherty, AH; Naccarelli, GV; Wiggins, S; Wolbrette, D | 1 |
10 review(s) available for moricizine and flecainide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Treatment of ventricular arrhythmias after CAST.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden, Cardiac; Electrocardiography, Ambulatory; Encainide; Flecainide; Heart Ventricles; Humans; Moricizine; Myocardial Infarction; Ventricular Function, Left | 1992 |
CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Double-Blind Method; Encainide; Flecainide; Humans; Moricizine; Multicenter Studies as Topic; Phenothiazines; Randomized Controlled Trials as Topic | 1990 |
Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Double-Blind Method; Encainide; Female; Flecainide; Humans; Male; Moricizine; Phenothiazines; Propranolol; Quinidine; Randomized Controlled Trials as Topic | 1990 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Clinical pharmacology of old and new antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Biological Availability; Bretylium Compounds; Disopyramide; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Tocainide | 1985 |
Clinical pharmacology of antiarrhythmic agents.
Topics: Adrenergic beta-Antagonists; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Calcium Channel Blockers; Electrophysiology; Encainide; Flecainide; Heart Conduction System; Humans; Lidocaine; Moricizine; Phenothiazines; Piperidines; Quaternary Ammonium Compounds; Sotalol; Tocainide | 1985 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Propafenone; Propiophenones; Tocainide | 1985 |
Investigational antiarrhythmic drugs for the treatment of ventricular rhythm disturbances.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Tocainide | 1984 |
27 trial(s) available for moricizine and flecainide
Article | Year |
---|---|
The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-II.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Flecainide; Humans; Moricizine; Myocardial Infarction; Survival Rate | 1992 |
Effects of advancing age on the efficacy and side effects of antiarrhythmic drugs in post-myocardial infarction patients with ventricular arrhythmias. The CAST Investigators.
Topics: Adult; Age Factors; Aged; Aging; Arrhythmias, Cardiac; Drug Therapy, Combination; Encainide; Flecainide; Follow-Up Studies; Humans; Logistic Models; Middle Aged; Moricizine; Myocardial Infarction; Prognosis; Stroke Volume | 1992 |
Proarrhythmic potential of moricizine: strengths and limitations of a data base analysis.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Encainide; Flecainide; Humans; Information Systems; Moricizine; Phenothiazines; Tachycardia | 1990 |
CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Double-Blind Method; Encainide; Flecainide; Humans; Moricizine; Multicenter Studies as Topic; Phenothiazines; Randomized Controlled Trials as Topic | 1990 |
Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. CAST Investigators.
Topics: Cardiac Complexes, Premature; Cause of Death; Drug Combinations; Electrocardiography; Encainide; Female; Flecainide; Follow-Up Studies; Heart Arrest; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Placebos; Risk Factors; United States | 1991 |
Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in the entire population enrolled.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction | 1991 |
Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in patients surviving open label titration but not randomized to double-blind therapy.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Regression Analysis | 1991 |
The events surrounding the removal of encainide and flecainide from the Cardiac Arrhythmia Suppression Trial (CAST) and why CAST is continuing with moricizine.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; Humans; Mass Media; Moricizine; National Institutes of Health (U.S.); Phenothiazines; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration | 1990 |
Implications of the Cardiac Arrhythmia Suppression Trial for antiarrhythmic drug treatment.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Europe; Flecainide; Humans; Moricizine; Multicenter Studies as Topic; Phenothiazines; Randomized Controlled Trials as Topic; Research Design; United States; United States Food and Drug Administration | 1990 |
Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Double-Blind Method; Encainide; Female; Flecainide; Humans; Male; Moricizine; Phenothiazines; Propranolol; Quinidine; Randomized Controlled Trials as Topic | 1990 |
CAST and beyond. Implications of the cardiac arrhythmia suppression trials. By the Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Flecainide; Humans; Moricizine; Multicenter Studies as Topic; Phenothiazines; Randomized Controlled Trials as Topic | 1990 |
Recruitment and baseline description of patients in the Cardiac Arrhythmia Pilot Study. The Cardiac Arrhythmia Pilot Study (CAPS) investigators.
Topics: Anilides; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Electrocardiography; Encainide; Feasibility Studies; Female; Flecainide; Humans; Imipramine; Male; Middle Aged; Moricizine; Myocardial Infarction; Phenothiazines; Pilot Projects; Random Allocation; Stroke Volume; United States | 1988 |
Congestive heart failure after acute myocardial infarction in patients receiving antiarrhythmic agents for ventricular premature complexes (Cardiac Arrhythmia Pilot Study).
Topics: Anilides; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Double-Blind Method; Encainide; Female; Flecainide; Heart Failure; Humans; Imipramine; Male; Middle Aged; Moricizine; Myocardial Infarction; Phenothiazines; Random Allocation; Stroke Volume | 1989 |
Relation of baseline characteristics to suppression of ventricular arrhythmias during placebo and active antiarrhythmic therapy in patients after myocardial infarction.
Topics: Anilides; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Encainide; Flecainide; Humans; Imipramine; Moricizine; Multicenter Studies as Topic; Myocardial Infarction; Phenothiazines; Pilot Projects; Random Allocation; Statistics as Topic; Stroke Volume | 1989 |
Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.
Topics: Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden; Encainide; Female; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Phenothiazines; Random Allocation | 1989 |
Lessons from the cardiac arrhythmia suppression trial.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Encainide; Flecainide; Humans; Moricizine; Myocardial Infarction; Phenothiazines; United States | 1989 |
Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Encainide; Female; Flecainide; Heart Failure; Humans; Imipramine; Male; Middle Aged; Moricizine; Myocardial Infarction; Phenothiazines; Random Allocation; Stroke Volume | 1988 |
Selection of an antiarrhythmic drug for a sudden-death-prevention trial.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Compounds; Clinical Trials as Topic; Death, Sudden; Encainide; Flecainide; Humans; Kinetics; Lidocaine; Mexiletine; Moricizine; Morpholines; Phenothiazines; Piperidines; Tocainide; Verapamil | 1982 |
Predicting mortality after myocardial infarction from the response of RR variability to antiarrhythmic drug therapy.
Topics: Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Electrocardiography, Ambulatory; Encainide; Female; Flecainide; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Risk Factors; Signal Processing, Computer-Assisted | 1994 |
Time to arrhythmic, ischemic, and heart failure events: exploratory analyses to elucidate mechanisms of adverse drug effects in the Cardiac Arrhythmia Suppression Trial.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Flecainide; Heart Failure; Humans; Moricizine; Myocardial Infarction; Myocardial Ischemia; Risk Factors; Survival Analysis; Time Factors | 1995 |
Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: analysis of the Cardiac Arrhythmia Suppression Trial.
Topics: Arrhythmias, Cardiac; Electrocardiography; Encainide; Female; Flecainide; Heart Failure; Humans; Male; Middle Aged; Moricizine; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Prognosis; Prospective Studies; Regression Analysis; Stroke Volume; Survival Analysis | 1995 |
Association between ease of suppression of ventricular arrhythmia and survival.
Topics: Aged; Cross-Over Studies; Encainide; Flecainide; Follow-Up Studies; Humans; Middle Aged; Moricizine; Risk Factors; Ventricular Fibrillation | 1995 |
Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST).
Topics: Arrhythmias, Cardiac; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Statistics as Topic; Survival Analysis | 1994 |
Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST).
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Survival Analysis; Ventricular Function, Left | 1993 |
Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial (CAST).
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Aspirin; Circadian Rhythm; Death, Sudden, Cardiac; Double-Blind Method; Encainide; Flecainide; Heart Arrest; Humans; Moricizine; Sympathetic Nervous System | 1994 |
Psychosocial predictors of mortality in the Cardiac Arrhythmia Suppression Trial-1 (CAST-1).
Topics: Arrhythmias, Cardiac; Chi-Square Distribution; Encainide; Flecainide; Humans; Moricizine; Myocardial Infarction; Prognosis; Psychological Tests; Psychology, Social; Regression Analysis; Social Support | 1993 |
The Cardiac Arrhythmia Suppression Trial: Implications for nursing practice.
Topics: Aged; Anti-Arrhythmia Agents; Critical Care; Death, Sudden, Cardiac; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Monitoring, Physiologic; Moricizine; Myocardial Infarction; Nursing Assessment; Survival Rate; Ventricular Premature Complexes | 1996 |
14 other study(ies) available for moricizine and flecainide
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
A proarrhythmic response to sodium channel blockade: modulation of the vulnerable period in guinea pig ventricular myocardium.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Flecainide; Guinea Pigs; Heart; In Vitro Techniques; Moricizine; Quinidine; Sodium Channels | 1992 |
[Medical management of arrhythmias; newer antiarrhythmic drugs].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Calcium Channel Blockers; Chlorobenzenes; Flecainide; Humans; Membrane Potentials; Moricizine; Piperidines; Propylamines; Pyridines; Sodium Channels | 1991 |
Use-dependent actions and effects on transmembrane action potentials of flecainide, encainide, and ethmozine in canine Purkinje fibers.
Topics: Action Potentials; Animals; Cell Membrane; Culture Techniques; Dogs; Encainide; Flecainide; Kinetics; Moricizine; Purkinje Fibers | 1991 |
The spectrum of CAST I and II.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Death, Sudden, Cardiac; Encainide; Flecainide; Humans; Moricizine; Randomized Controlled Trials as Topic | 1991 |
Crime, misdemeanor, and arrhythmia decoding CAST.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Encainide; Flecainide; Heart Ventricles; Humans; Moricizine; Myocardial Infarction; Randomized Controlled Trials as Topic; Research Design; Risk Factors | 1991 |
Drug classification and actions.
Topics: Anilides; Anti-Arrhythmia Agents; Encainide; Flecainide; Humans; Moricizine | 1991 |
The healthy responder phenomenon in non-randomized clinical trials. CAST Investigators.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Data Interpretation, Statistical; Double-Blind Method; Electrocardiography, Ambulatory; Flecainide; Humans; Moricizine; Myocardial Infarction; Randomized Controlled Trials as Topic | 1991 |
Inhibition of ICa in single frog cardiac cells by quinidine, flecainide, ethmozin, and ethacizin.
Topics: Animals; Anti-Arrhythmia Agents; Calcium Channels; Flecainide; Heart; In Vitro Techniques; Membrane Potentials; Moricizine; Phenothiazines; Quinidine; Rana esculenta | 1989 |
New drugs in the management of ventricular arrhythmias.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Compounds; Drug Interactions; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Propafenone; Propiophenones; Tocainide | 1984 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil | 1984 |
A critical appraisal of the cardiac arrhythmia suppression trial (CAST).
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Encainide; Flecainide; Humans; Imipramine; Moricizine; Multicenter Studies as Topic; Pilot Projects; Randomized Controlled Trials as Topic; Risk Factors | 1991 |